Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations

Kathryn Rae Wagner, Sherifa Hamed, Donald W. Hadley, Andrea L. Gropman, Aaron H. Burstein, Diana M. Escolar, Eric P. Hoffman, Kenneth H. Fischbeck

Research output: Contribution to journalArticle

Abstract

Aminoglycosides have previously been shown to suppress nonsense mutations, allowing translation of full-length proteins in vitro and in animal models. In the mdx mouse, where muscular dystrophy is due to a nonsense mutation in the dystrophin gene, gentamicin suppressed truncation of the protein and ameliorated the phenotype. A subset of patients with Duchenne and Becker muscular dystrophy similarly possess a nonsense mutation, causing premature termination of dystrophin translation. Four such patients, with various stop codon sequences, were treated once daily with intravenous gentamicin at 7.5 mg/kg/day for 2 weeks. No ototoxicity or nephrotoxicity was detected. Full-length dystrophin was not detected in pre- and post-treatment muscle biopsies.

Original languageEnglish (US)
Pages (from-to)706-711
Number of pages6
JournalAnnals of Neurology
Volume49
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Dystrophin
Duchenne Muscular Dystrophy
Nonsense Codon
Gentamicins
Inbred mdx Mouse
Muscular Dystrophies
Terminator Codon
Aminoglycosides
Proteins
Therapeutics
Animal Models
Phenotype
Biopsy
Muscles
Genes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Wagner, K. R., Hamed, S., Hadley, D. W., Gropman, A. L., Burstein, A. H., Escolar, D. M., ... Fischbeck, K. H. (2001). Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Annals of Neurology, 49(6), 706-711. https://doi.org/10.1002/ana.1023

Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. / Wagner, Kathryn Rae; Hamed, Sherifa; Hadley, Donald W.; Gropman, Andrea L.; Burstein, Aaron H.; Escolar, Diana M.; Hoffman, Eric P.; Fischbeck, Kenneth H.

In: Annals of Neurology, Vol. 49, No. 6, 2001, p. 706-711.

Research output: Contribution to journalArticle

Wagner, KR, Hamed, S, Hadley, DW, Gropman, AL, Burstein, AH, Escolar, DM, Hoffman, EP & Fischbeck, KH 2001, 'Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations', Annals of Neurology, vol. 49, no. 6, pp. 706-711. https://doi.org/10.1002/ana.1023
Wagner, Kathryn Rae ; Hamed, Sherifa ; Hadley, Donald W. ; Gropman, Andrea L. ; Burstein, Aaron H. ; Escolar, Diana M. ; Hoffman, Eric P. ; Fischbeck, Kenneth H. / Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. In: Annals of Neurology. 2001 ; Vol. 49, No. 6. pp. 706-711.
@article{c4a1aeff528042c4a5f558111fa607bf,
title = "Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations",
abstract = "Aminoglycosides have previously been shown to suppress nonsense mutations, allowing translation of full-length proteins in vitro and in animal models. In the mdx mouse, where muscular dystrophy is due to a nonsense mutation in the dystrophin gene, gentamicin suppressed truncation of the protein and ameliorated the phenotype. A subset of patients with Duchenne and Becker muscular dystrophy similarly possess a nonsense mutation, causing premature termination of dystrophin translation. Four such patients, with various stop codon sequences, were treated once daily with intravenous gentamicin at 7.5 mg/kg/day for 2 weeks. No ototoxicity or nephrotoxicity was detected. Full-length dystrophin was not detected in pre- and post-treatment muscle biopsies.",
author = "Wagner, {Kathryn Rae} and Sherifa Hamed and Hadley, {Donald W.} and Gropman, {Andrea L.} and Burstein, {Aaron H.} and Escolar, {Diana M.} and Hoffman, {Eric P.} and Fischbeck, {Kenneth H.}",
year = "2001",
doi = "10.1002/ana.1023",
language = "English (US)",
volume = "49",
pages = "706--711",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations

AU - Wagner, Kathryn Rae

AU - Hamed, Sherifa

AU - Hadley, Donald W.

AU - Gropman, Andrea L.

AU - Burstein, Aaron H.

AU - Escolar, Diana M.

AU - Hoffman, Eric P.

AU - Fischbeck, Kenneth H.

PY - 2001

Y1 - 2001

N2 - Aminoglycosides have previously been shown to suppress nonsense mutations, allowing translation of full-length proteins in vitro and in animal models. In the mdx mouse, where muscular dystrophy is due to a nonsense mutation in the dystrophin gene, gentamicin suppressed truncation of the protein and ameliorated the phenotype. A subset of patients with Duchenne and Becker muscular dystrophy similarly possess a nonsense mutation, causing premature termination of dystrophin translation. Four such patients, with various stop codon sequences, were treated once daily with intravenous gentamicin at 7.5 mg/kg/day for 2 weeks. No ototoxicity or nephrotoxicity was detected. Full-length dystrophin was not detected in pre- and post-treatment muscle biopsies.

AB - Aminoglycosides have previously been shown to suppress nonsense mutations, allowing translation of full-length proteins in vitro and in animal models. In the mdx mouse, where muscular dystrophy is due to a nonsense mutation in the dystrophin gene, gentamicin suppressed truncation of the protein and ameliorated the phenotype. A subset of patients with Duchenne and Becker muscular dystrophy similarly possess a nonsense mutation, causing premature termination of dystrophin translation. Four such patients, with various stop codon sequences, were treated once daily with intravenous gentamicin at 7.5 mg/kg/day for 2 weeks. No ototoxicity or nephrotoxicity was detected. Full-length dystrophin was not detected in pre- and post-treatment muscle biopsies.

UR - http://www.scopus.com/inward/record.url?scp=0034982292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034982292&partnerID=8YFLogxK

U2 - 10.1002/ana.1023

DO - 10.1002/ana.1023

M3 - Article

VL - 49

SP - 706

EP - 711

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -